Clinical applications for ESTETROL (cas 15183-37-6)

Add time:07/30/2019    Source:sciencedirect.com

In this paper the potential clinical applications for the human fetal estrogen estetrol (E4) are presented based on recently obtained data in preclinical and clinical studies. In the past E4 has been classified as a weak estrogen due to its rather low estrogen receptor affinity. However, recent research has demonstrated that due to its favorable pharmacokinetic properties, especially the slow elimination and long half-life, E4 is an effective orally bioavailable estrogen agonist with estrogen antagonistic effects on the breast in the presence of estradiol. Based on the pharmacokinetic properties, the pharmacological profile and the safety and efficacy results in human studies, E4 seems potentially suitable as a drug for human use in applications such as hormone replacement therapy (vaginal atrophy and vasomotor symptoms), contraception, osteoporosis and breast cancer.

We also recommend Trading Suppliers and Manufacturers of ESTETROL (cas 15183-37-6). Pls Click Website Link as below: cas 15183-37-6 suppliers

Prev:Effect of ESTETROL (cas 15183-37-6), a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis
Next:Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating ESTETROL (cas 15183-37-6) to prevent cerebral ischemia of premature babies)